Cryo-electron microscopy (cryo-EM) has revolutionized structural biology, offering unparalleled insights into the 3D structures of biological macromolecules. Obtaining high-resolution structures relies heavily on the quality of the sample preparation, a critical step that can vary significantly depending on the nature of the sample – whether it's a soluble protein, a virus particle, or a challenging membrane protein.
Effective cryo EM sample preparation techniques aim to preserve the biological sample in a near-native state, typically embedded in a thin layer of vitreous ice. This avoids the artifacts introduced by traditional staining or crystallization methods. However, achieving optimal sample quality for cryo-EM can be complex, involving multiple steps and considerations unique to each sample type. Challenges such as air-water interface disruption, preferential orientation, and aggregation must be meticulously addressed to ensure successful data collection and high-resolution reconstruction.
Shuimu BioSciences offers comprehensive "One-Stop" solutions that encompass the entire workflow from gene sequences to high-resolution 3D structures, including specialized protein preparation and analysis services designed to address the nuances of different sample types. By integrating protein expression, purification, and characterization with cutting-edge cryo-EM services, Shuimu minimizes variability and standardizes the pipeline.
To explore Shuimu's integrated approach and discuss your specific sample preparation needs, please visit https://shuimubio.com/.
General Principles for Protein Sample Preparation in Cryo-EM
For many biological macromolecules, successful cryo-EM Single Particle Analysis (SPA) starts with obtaining highly pure and homogeneous samples. The sources emphasize the importance of protein purity, often requiring purity greater than 90% for negative staining and up to 95% for crystallization services. For cryo-EM SPA itself, detailed purity requirements are part of the sample submission guidelines, noting the need for purity ≥ 90%. Concentration is also key, with general protein solutions for SPA requiring a concentration ≥ 2mg/mL and a volume ≥ 100ul.
Sample integrity is paramount. Samples should be handled carefully to minimize damage. This includes minimizing repeated freeze-thaw cycles, with recommendations to aliquot samples after preparation and use freshly prepared samples whenever possible.
Buffer conditions play a critical role in sample behavior and cryo-EM compatibility. Buffers should ideally be free from substances that can interfere with imaging or freezing, such as polysaccharides, DMSO, glycerol, and other organic substances, which can affect contrast or ice formation. Salt ion concentration should ideally be below 300 mM. Shuimu's protein preparation services include processes like size-exclusion chromatography (gel filtration) to ensure higher purity and uniformity. They also perform protein quality control using techniques like SDS-PAGE, Western blot, and mass spectrometry to verify sample identity and purity.
Shuimu provides extensive protein preparation and analysis services, including various expression systems like E. coli, mammalian cells, insect cells, and cell-free systems. They also offer diverse purification processes such as affinity chromatography, ion-exchange chromatography, gel filtration, and reverse-phase HPLC (RP-HPLC). This comprehensive upstream capability is crucial for generating the high-quality protein needed for cryo-EM.
Sample Preparation for Viruses, VLPs, and Vaccine Components
Cryo-EM is a powerful tool in the vaccine field, used for viral structure analysis, vaccine quality control, and studying antibody-vaccine interactions. Sample preparation for viruses, virus-like particles (VLPs), liposomes, and lipid nanoparticles (LNPs) has specific considerations.
For viruses and viral vectors like AAV, suggested sample requirements include specific power levels (e.g., e13 for viruses) and a minimum volume (at least 50μl/sample). Liposomes require a concentration of 1mg/ml. LNPs may require higher concentrations, with suggestions around 10mg/ml, as low concentrations (e.g., 3mg/ml) might not enter the holes in the cryo-EM grid. Additionally, high sugar content (<10%) in the buffer can affect image contrast.
Initial assessment of viral or particle samples often utilizes Negative Staining. This technique provides low-resolution 2D projection images useful for quickly assessing particle size, uniformity, morphology, density, integrity, and aggregation state at a lower cost than cryo-EM. It is commonly used for observing viruses, nanoparticles, organelles, and protein complexes. Factors like particle aggregation and the presence of organic substances (polysaccharides, DMSO, glycerol) can affect negative staining results.
For detailed characterization of nanoparticles like AAV, liposomes, LNPs, and VLPs, Shuimu employs Cryo-Characterization using their self-developed AI system, NanoSMART. This system automatically identifies nanoparticle features such as size distribution, roundness, and layered full/empty integrity from electron microscope images. NanoSMART is noted for its excellent performance in identifying ultra-small targets like VLPs and provides powerful data analysis functions and user-friendly data presentation.
Understanding particle morphology and integrity through cryo-EM is critical for vaccine quality control, detecting issues during production. Accurate measurement of aggregation levels in vaccine components via cryo-EM is also vital for enhancing immunogenicity.
Discover how Shuimu's specialized services can support your virus, VLP, and vaccine research by visiting https://shuimubio.com/.
Membrane Protein Preparation for Cryo-EM
Membrane protein preparation is notoriously challenging compared to soluble proteins due to their hydrophobic nature and dependence on a lipid environment for stability and function. Many important drug targets, such as G protein-coupled receptors (GPCRs), ion channels, and transporters, are membrane proteins. Obtaining stable, homogeneous, and correctly folded membrane protein samples is often the most significant hurdle in determining their structures.
Shuimu BioSciences highlights its extensive experience in the production and purification method design specifically for membrane proteins, including GPCRs, ion channels, and transport proteins. They understand that these proteins often require specific detergents or lipidic environments to remain soluble and active outside of the cell membrane.
The "One-Stop" solution offered by Shuimu includes enhancing upstream capabilities in protein production to successfully address the challenges posed by difficult-to-express proteins, including membrane proteins. They utilize various expression systems, but mammalian cells are often preferred for expressing membrane proteins due to their ability to perform native-like post-translational modifications and folding. Cell-free systems are also mentioned as suitable for transmembrane proteins. Purification processes like affinity chromatography are commonly used for membrane proteins with specific tags.
Shuimu maintains an Off-the-Shelf Protein List which includes a variety of important membrane protein targets such as GPR75, GPR88, GPR35, GPR174, GPR734 (all GPCRs), OX-2, CCR7, ASCT2, UCP1, SLC18A1, TMEM16A, SLC2A17, and TMEM119. This indicates their capability and experience in handling these complex targets.
Case studies provided in the sources showcase Shuimu's success in resolving structures of membrane proteins using their cryo-EM platform, including ion channels (human GluN1-GluN2A NMDA receptor) and GPCRs (human histamine H1 receptor/Gq complex, human bradykinin receptors, κ-opioid receptor-Gi complex, active GPR75 with a nanobody). Published articles also list resolved structures of other membrane proteins like human Nav1.7, CCR2 and CCR3 chemokine receptors, D1 dopamine receptor, adhesion GPCRs, polyamine transporter ATP13A2, multidrug transporter MRP4, and calcium pump SPCA1.
These examples underscore that while challenging, successful membrane protein preparation is achievable with the right expertise and integrated workflow, a core offering at Shuimu BioSciences.
Learn more about Shuimu's expertise in membrane protein structure determination at https://shuimubio.com/.
Addressing Common Sample Challenges with Advanced Techniques
Beyond the specific requirements of different sample types, cryo-EM sample preparation faces common hurdles. These include challenges posed by samples with small protein molecular weight, low concentration, high background noise, and issues arising from the air-water interface or severe preferential orientation. These factors can significantly hinder data collection and 3D reconstruction.
To overcome the bottleneck of sample preparation, Shuimu has developed and utilizes advanced techniques. Their proprietary GraFuture™ graphene support grids offer a potential solution to the preferred orientation problem and are suitable for applications involving small protein molecular weight, low concentration, strong background noise, and gas-liquid interface damage. By providing an alternative surface for particles, these grids can improve particle distribution and orientation, leading to more isotropic data and better reconstructions.
Shuimu's AI-Driven Platform, including the SMART software suite, also plays a role in mitigating sample issues by streamlining data analysis and reducing required data volume and machine runtime. This allows for more efficient processing of potentially suboptimal datasets resulting from sample challenges.
Integrated Workflow and Quality Assurance
Shuimu BioSciences provides a comprehensive "One-Stop" SPA solution workflow. This workflow typically involves Project Consultation & Discussions, Feasibility Evaluation, Strategy Definition, Contract & Payment, Protein Expression & Purification, Negative Staining (for initial assessment), Sample Freezing & Data Collection, 2D Particle Picking, 3D Reconstruction, Model Refinement, and final Data Delivery. This integrated approach ensures that potential issues with sample quality are identified and addressed early in the process.
Quality control is integrated throughout the process. From initial protein characterization using techniques like SDS-PAGE and mass spectrometry, to preliminary assessment via negative staining, to detailed nanoparticle analysis with Cryo-Characterization/NanoSMART, Shuimu ensures that samples meet the necessary standards for high-resolution cryo-EM. Their strict quality control system is based on rigorous cryo-electron microscopy analysis and characterization.
With cutting-edge equipment, an elite scientist team, extensive experience, and an uncompromising pursuit of resolution (achieving resolutions down to 1.4Å and solving structures as small as 51 kDa), Shuimu is well-equipped to handle diverse and challenging samples.
For unparalleled expertise in cryo em sample preparation techniques, membrane protein preparation, and comprehensive structural analysis services, turn to Shuimu BioSciences. Visit https://shuimubio.com/ to learn more and partner with world-class experts.